Table 1.
Correlation of Ese-3 expression with clinicopathological features of CC
| Parameters | Total (n) | Ese-3 expression (IHC) | ||||
|---|---|---|---|---|---|---|
|
| ||||||
| Low | High | χ 2 | P value | r | ||
| Gender | ||||||
| Male | 49 | 10 | 39 | 0.654 | 0.419 | 0.077 |
| Female | 51 | 15 | 36 | |||
| Age (years) | ||||||
| <60 | 17 | 3 | 14 | 0.213 | 0.645 | 0.103 |
| ≥60 | 83 | 22 | 61 | |||
| T | ||||||
| I | 1 | 0 | 1 | 8.478 | 0.037* | 0.3078 |
| II | 5 | 2 | 3 | |||
| III | 75 | 14 | 61 | |||
| IV | 18 | 9 | 9 | |||
| N | ||||||
| N0 | 60 | 13 | 47 | 0.500 | 0.480 | 0.094 |
| N1-2 | 40 | 12 | 28 | |||
| TNM stage | ||||||
| I | 6 | 2 | 4 | 3.957 | 0.266 | 0.1872 |
| II | 54 | 11 | 43 | |||
| III | 49 | 11 | 38 | |||
| IV | 1 | 1 | 0 | |||
| Pathological grade | ||||||
| I | 22 | 2 | 20 | 4.064 | 0.131 | 0.1976 |
| II | 73 | 22 | 51 | |||
| III | 5 | 1 | 4 | |||
*
Statistically significant (P<0.05).